Biotech Values

[DaveAu]

Looks like BMO must have a new biotech analyst. The link below has a short summary of his opinion on the below companies.

http://www.bmonesbittburns.com/IA/IAHomepage/NewsToBrowser.asp?IA_ID=NCHOWBAY&LANGUAGE=EN&NEWS_ID=426&VERSION=305

Initiating Coverage
Chefs’ Warehouse: A Long Runway for Growth K. Short 8
Amgen: Initiating Coverage With Outperform Rating J. Birchenough 12
Ariad Pharmaceuticals: Initiating Coverage With Outperform Rating J. Birchenough 14
Cardiome Pharmaceuticals: Initiating Coverage at Outperform J. Birchenough 16
Celgene: Initiating Coverage With Outperform and $90 Price Target J. Birchenough 18
Halozyme Therapeutics: Initiating Coverage With Outperform Rating J. Birchenough 20
Human Genome Sciences: Initiating Coverage With Outperform Rating J. Birchenough 22
Isis Pharmaceuticals: Initiating With Outperform Rating and $15 Target J. Birchenough 24
Regeneron Pharmaceuticals: Initiating Coverage With Outperform Rating J. Birchenough 26
Rigel Pharmaceuticals: Initiating With Outperform Rating and $17 Target J. Birchenough 28
United Therapeutics: Initiating Coverage With Outperform and $54 Price Target J. Birchenough 30
Amylin Pharmaceuticals: Initiating Coverage With Market Perform J. Birchenough 32
Arena Pharmaceuticals: Initiating Coverage With Market Perform J. Birchenough 34
Array BioPharma: Initiating With Market Perform Rating J. Birchenough 36
Gilead Sciences: Initiating Coverage With Market Perform Rating J. Birchenough 38
NPS Pharmaceuticals: Initiating Coverage With Market Perform Rating J. Birchenough 40
Onyx Pharmaceuticals: Initiating Coverage With Market Perform Rating and $34 Target J. Birchenough 42
Synta Pharmaceuticals: Initiating Coverage With Market Perform Rating J. Birchenough 44
ZIOPHARM Oncology: Initiating Coverage With Market Perform J. Birchenough 46
Biogen Idec: Initiating Coverage at Underperform With $74 Price Target J. Birchenough 48
Genomic Health: Initiating Coverage at Underperform J. Birchenough 50